IGF1 and metabolic syndrome: The frequencies of dyslipidemia (16 (94.1%) vs. 30 (63.8%), P = 0.025) and hyperuricemia (15 (88.2%) vs. 19 (40.4%), P < 0.001) were significantly higher in the low than in the standard IGF-1 group.